Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans

Nephrology Dialysis Transplantation

Volumn 12, Issue 5, 1997, Pages 933-938

  Fliser, D ^a   Franek, E ^a   Fode, P ^a   Stefanski, A ^a   Schmitt, C P ^a   Lyons, M ^a   Ritz, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood pressure; Euglycaemic clamp; Hyperparathyroidism; Hypertension; Insulin sensitivity; Intracellular calcium; Parathyroid hormone

Indexed keywords

CALCIUM ION; ELECTROLYTE; PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROLYTE URINE LEVEL; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEAN ARTERIAL PRESSURE; MUSCLE BLOOD FLOW; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SECONDARY HYPERPARATHYROIDISM; THROMBOCYTE; UREMIA; VASODILATATION;

ADULT; ANIMALS; BLOOD GLUCOSE; BLOOD PLATELETS; BLOOD PRESSURE; CALCIUM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; PARATHYROID HORMONE; TERIPARATIDE;

EID: 0030988118     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.5.933     Document Type: Article

References (33)

1. Raine AEG, Bedford L, Simpson AWM, Ashley CC, Brown R, Woodhead JS, Ledingham JGG. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Intern 1993; 43: 700-705
2. Brickman AS, Nyby MD. Parathyroid disease and hypertension. In: JL Laragh, BM Brenner, eds. Hypertension, 2nd edn, Raven Press, New York, 1995: 89-98
3. Schiffl H, Lang S, Fricke H, Sitter T. Hypertension in primary hyperparathyroidism: the role of noradrenergic blood pressure response and abnormal cytosolic calcium. Kidney Blood Press Res 1996; 19: 54a
4. Pang PKT, Tenner TE, Yee JA, Yang M, Janssen HF. Hypotensive action of parathyroid hormone preparations on rats and dogs. Proc Natl Acad Sci 1980; 77: 675-678
5. Massry SG, Iseki K, Campese VM. Serum calcium, parathyroid hormone, and blood pressure. Am J Nephrol 1986; 6(Suppl. 1): 19-28
6. Gennari C, Nami R, Bianchini C, Aversa AM. Blood pressure effects of acute hypercalcemia in normal subjects and thyroparathyroidectomized patients. Mineral Electrolyte Metab 1985; 11: 369-373.
7. Mann JFE, Wiecek A, Bommer J, Ganten U, Ritz E. Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 1987; 45: 46-52.
8. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-572.
9. Mak RHK, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382.
10. Fliser D, Rett C, Hübinger A, Ritz E. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. Nephrol Dial Transplant 1995; 10: 643-647.
11. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985; 75: 1037-1044
12. Levi E, Fadda GZ, Thanakitcharu P, Massry SG. Chronology of cellular events leading to derangements in function of pancreatic islets in chronic renal failure. J Am Soc Nephrol 1992; 3: 1139-1146
13. Lu KC, Shieh SD, Lin SH, Chyr SH, Lin YF, Diang LK, Li BL, Sheu WHH, Ding YA. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. Quart J Med 1994; 87: 359-365
14. Kumar S, Olukoga AO, Gordon C, Mawer EB, France M, Hosker JP, Davies M, Boulton AJM. Impaired glucose tolerance and insulin sensitivity in primary hyperparathyroidism. Clin Endocrinol 1994; 40: 47-53
15. Moore RD. Effects of insulin upon ion transport. Biochem Biophys Acta 1983; 37: 1-49
16. + antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol 1992; 3: 1049-1063
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
18. Blind E, Schmidt-Gayk H, Armbruster FP, Stadler A. Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clin Chem 1987; 33: 1376-1381
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450
20. Erne P, Bolli P, Burgisser E, Bühler FR. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 1984; 310: 1084-1088
21. Resnick LM. Calciotropic hormones in salt-sensitive essential hypertension: Calcitriol and parathyroid hypertensive factor. J Hypertens 1994; 12(Suppl. 1): S3-S9
22. Van Hooft IMS, Grobbee DE, Fröhlich M, Pols HA, Hofman A. Alterations in calcium metabolism in young people at risk for hypertension. Hypertension 1993; 21; 267-272
23. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects, J Clin Hypertens 1986; 4: 360-370
24. Kawashima H. Parathyroid hormone causes a transient rise in intracellular ionized calcium in vascular smooth muscle cells. Biochem Biophys Res Commun 1990; 166: 709-714
25. Anderson EA, Mark AL. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993; 21: 136-141
26. Nowicki M, Fliser D, Fode P, Ritz E. Changes in plasma phosphate levels influences insulin sensitivity under euglycaemic conditions. J Clin Endocrinol Metab 1996; 81: 156-159
27. Rumenapf G, Schmidtler J, Schwille PO. Intestinal calcium absorption during hyperinsulinaemic euglycaemic glucose clamp in healthy humans. Calcif Tissue Int 1990; 46: 73-79
28. Erne P, Resink TJ, Bürgisser E, Bühler FR. Platelets and hypertension. J Cardiovasc Pharmacol 1985; 7(Suppl. 6): 103-108
29. 3 in response to parathyroid hormone in patients with incipient renal failure. Nephron 1991; 57: 314-318.
30. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Intern 1995; 47: 200-206
31. Plehwe WE, Wiliams PF, Caterson ID, Harrison LC, Turtle JR. Calcium-dependence of insulin receptor phosphorylation. Biochem J 1993; 214: 361-366
32. Draznin B, Sussman K, Kao M, Leweis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987; 262: 14385-14388
33. Mak RHK. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Intern 1992; 41: 1049-1054